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Introduction
Studies carried out on resistant and sensitive tumor cells to
antineoplastic drugs, suggest that the increase in the expression of
Sirt1, which is a gene associated with an increase in longevity, may
represent a phenomenon general associated with resistance to
chemotherapy, independent of cell type or drug used to induce
resistance.
So, if this gene is associated with aging and is also associated with the
process of resistance to chemotherapy, it is possible that other genes
could be involved in both processes.
Therefore, the identification of genes involved in chronological aging
could have a potential utility as molecular markers in the
chemotherapy treatment of cancer.
Objectives
The aim of this work is to study the relationship between the
chronological aging and the resistance to Bleomycin for the purpose of
establish the basic interactions between these phenomenons for
further investigation of molecular markers.
Material and methods
Yeast strain and culture medium
The experiments were carried out with the haploid yeast strain
Saccharomyces cerevisiae WS8105-1C (genotype: MATalpha, ade2, arg4-17,
trp1-289, ura3-52) and with the resistant haploid yeast strain to bleomycin
Saccharomyces cerevisiae WS8105-1CR 0.158 Bleo. Yeast cells were grown
in a liquid medium of SDC (2% dextrose, 0,17% nitrogen base, 0,5%
ammonium sulphate [(NH4)2SO4], 0,15 % four-fold excess of the
supplements ade, arg, trp and ura) for the aging assay, and in a solid
medium of YPD (1 % Bacto-yeast extract, 2 % Bacto-peptone, 2 % dextrose
and 2 % Bacto-agar) for the cytotoxicity assay.
Chemicals
The antineoplastic drug used was bleomycin. The doses used were 0, 0.001,
0.003, 0.005, 0.008, 0.01, 0.03 y 0.06 UI/ml for the cytotoxicity assay.
Experimental protocol
Aging assay: Yeast cells were cultured during five days on YPD-agar plates
at 30°C. Next, 1.5E+6 cells/ml were added to test flask with 20 ml of SDC
medium. They were cultured during 4 days at 30°C, shaking at 300 rpm
until they reached the stationary phase. From that moment, the
chronological aging phase began and it was evaluated every two or three
days by droptest, so six 10-fold serial dilutions from each sample were
prepared and five-microliter aliquots of each dilution were spotted onto
YPD plates. Finally, the surviving fraction was calculated.
Cytotoxicity test: Prior to exposures, yeast cells were cultured during five
days on YPD-agar plates at 30°C and then a loop was suspended in 1000 μl
of sterile water at a titer of 2E+7 cells/ml. This quantity of cells was added
to test tubes with different doses of bleomycin and they were completed
with sterile water until 1000 μl. Then, the tubes were cultured during 24
hours at 30°C and cells washed twice with sterile water. For drop test assay,
six 10-fold serial dilutions from each sample were prepared and five-
microliter aliquots of each dilution were spotted onto YPD plates. The same
test was carried out to the resistant strain WS8105-1C-R 0.158 Bleo.
Results and Conclusions
The aging test lasted 31 days. It was observed that in the strain
WS8105-1C-R 0.158 Bleo (resistant to bleomycin) there was a delay
of aging with respect to the wild strain. In the wild strain there was a
sharp fall of the surviving fraction (FS). It was asymptotized on day 3
and with a FS value of 0.04. In contrast, in strain WS8105-1C-
R300cisPt the FS fall was less sudden, and it was asymptotized on day
24 with a FS value of 0.04.
The FS50 was calculated obtaining a result of 1.61 days for the wild
strain and a result of 13.48 days for the strain WS8105-1C-R 0.158
Bleo. Therefore, there was a delay in aging in the strain WS8105-1C-R
0.158 Bleo, with respect to the wild strain, of 8.37 days.
In the wild strain, the ID50 and ID90 values obtained were 0.001
UI/ml and 0.158 UI/ml, respectively. In the resistant strain WS8105-
1C-R 0.158 Bleo, the ID50 and ID90 values obtained were 0.0156
UI/ml (15.6 times more resistant with respect to the wild strain) and
2.818 UI/ml (17.83 times more resistant with respect to the wild
strain), respectively. Thus, it was observed that for the ID50 and ID90
values there was an increase in resistance associated with an
increase in the aging delay, with respect to the wild strain.
In conclusion, the strain WS8105-1C-R 0.158 Bleo (resistant to
bleomycin) presents an increase in the chronological life cycle,
producing a delay in aging. Common cellular and molecular
mechanisms between the acquisition of resistance to this drug and
the delay in cellular aging could be influencing the results obtained.
Therefore, the results obtained establish that basic mechanism such
as drug resistance and aging are related. Similar molecular markers
could be activated which could be very useful in the diagnosis and
treatment of cancer.
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